Trial Profile

Study of the Influence of Immunological Repeated Stimuli With Commercial Vaccines Over the Viral Load (VL), Resistance Development and Specific Immunological Response Against HIV in Early Stage HIV Patients With Undetectable VL After HAART

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Antiretrovirals; Diphtheria-tetanus vaccine; Hepatitis A vaccine inactivated; Hepatitis B vaccine; Hepatitis B vaccine recombinant; Influenza virus vaccine; Measles mumps and rubella virus vaccine; Pneumococcal vaccine; Varicella zoster virus vaccine; Varicella zoster virus vaccine live
Indications Chickenpox; Diphtheria; Hepatitis A; Hepatitis B; HIV-1 infections; Influenza A virus infections; Influenza B virus infections; Influenza virus infections; Measles; Mumps; Otitis media; Pneumococcal infections; Pneumonia; Rubella; Tetanus
Focus Pharmacodynamics; Therapeutic Use
Acronyms EARTH-06

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com